The coronavirus will affect the medical supply chain coming from China. Various reports indicate that while 50% of Chinese factories are now open, only about half of these are actually producing medical products. Many Chinese employees are still working from home. While... Read More
With the COVID-19 virus shaking global markets and economies, anti-viral drug developers around the world are increasing efforts to develop treatments for the disease. Western pharmaceutical firms and research organizations have launched accelerated research and testing programs for novel coronavirus vaccines. Among... Read More
With the incidence of non-communicable diseases rising in Malaysia and as household incomes grow, the Southeast Asian nation presents fertile ground for both the pharmaceutical and medical device industries. According to analyst GlobalData, the medical device market in the country, worth $1.28... Read More
This article was originally published on Medtech Intelligence. Artificial intelligence devices or products, known popularly as AI, imitate intelligent behavior or mimic human learning and reasoning. In its more basic forms, artificial intelligence has been used in the healthcare field to perform... Read More
Fueled by a lack of access to preventative eye care and a dearth of public vision screening programs, myopia, and other ophthalmologic conditions are on the rise in East Asia. In one city in China, a 15-year study completed in 2015 found... Read More
As China’s drug market grows exponentially, more foreign API, excipient and drug packaging material companies look to sell their products in China. In August 2016, to simplify the drug review procedure, the former CFDA announced that the review and approval of APIs,... Read More
Systematic evaluations of the effects of health technologies in Japan, China, and South Korea conducted over the past three years are showing success in determining the clinical benefits and cost-effectiveness of widely used drugs, adjusting pricing of drugs and medical devices and... Read More
In a bid to reduce prices of sorely needed medical devices, China is set to expand a trial bulk purchase program that has made coronary stents, pacemakers, prosthetics and other medical devices more affordable in the provinces of Jiangsu and Anhui. Under... Read More
Building on its record as South Korea’s transportation and industrialization hub, the city of Incheon, outside Seoul, is initiating plans to build new facilities to attract international biotechnology companies and research institutions. The planned expansion of the Songdo Global Biotech Cluster will... Read More
This article was originally published on MedTech Intelligence. Driven by an aging population with growing needs for new medical technologies—and more means to pay for them—governments and hospitals in China, Japan, Singapore, Thailand and Korea are joining forces to purchase an increasing... Read More